• Proteina plans to issue KRW 29.2 billion of unsecured convertible bonds through a private placement.
• Payment is scheduled for November 12, 2026; the bonds mature November 12, 2031.
• The bonds carry a 0% coupon with a 1% yield to maturity.
• Conversion at KRW 48,061 per share would result in 607,561 new common shares.
• Proceeds will fund KRW 20.8 billion of AI Biofoundry facilities investment, with KRW 8.4 billion allocated to research and drug development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Proteina Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261104000317), on November 04, 2026, and is solely responsible for the information contained therein.